Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis.

Sun H, Yuan Y, Wang P, Cai R, Xia W, Huang R, Wang S.

Lipids Health Dis. 2015 Nov 2;14:140. doi: 10.1186/s12944-015-0147-6.

2.

Diabetogenic effect of statins: a double-edged sword?

Yoon JS, Lee HW.

Diabetes Metab J. 2013 Dec;37(6):415-22. doi: 10.4093/dmj.2013.37.6.415.

3.

Clinical lipid control success rate before and after percutaneous coronary intervention in iran; a single center study.

Hosseini SK, Tahvildari M, Alemzadeh Ansari MJ, Nakhjavani M, Esteghamati A, Lotfi Tokaldany M.

Iran Red Crescent Med J. 2013 Jun;15(6):467-72. doi: 10.5812/ircmj.3370. Epub 2013 Jun 5.

4.

Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial.

Goswami NJ, Dekoven M, Kuznik A, Mardekian J, Krukas MR, Liu LZ, Bailey P, Deitrick C, Vincent J.

Int J Gen Med. 2013 Jul 30;6:647-55. doi: 10.2147/IJGM.S47518. Print 2013.

5.

Presenting the improved possibility for staying well might be better than talking about change in risk: use of the non-occurrence probability increase (NOPI).

Hagström B, Gunnarsson RK, Rosenfeld M.

Scand J Prim Health Care. 2013 Sep;31(3):138-40. doi: 10.3109/02813432.2013.811951. Epub 2013 Jul 29.

6.

Risk of incident diabetes among patients treated with statins: population based study.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM.

BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610. Erratum in: BMJ. 2013;347:f4356.

7.

Preventive pharmacotherapy in type 2 diabetes mellitus.

Choudhary N, Kalra S, Unnikrishnan AG, Ajish TP.

Indian J Endocrinol Metab. 2012 Jan;16(1):33-43. doi: 10.4103/2230-8210.91183.

8.

The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.

Wang W, Ma L, Zhang Y, Deng Q, Liu M, Liu L.

J Hum Hypertens. 2011 Apr;25(4):271-7. doi: 10.1038/jhh.2010.45. Epub 2010 May 6.

9.

Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM.

Diabetes Care. 2009 Oct;32(10):1924-9. doi: 10.2337/dc09-0738.

10.

The prevention of type 2 diabetes.

Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group.

Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. doi: 10.1038/ncpendmet0843. Epub 2008 May 20. Review.

12.

The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic.

Pearson GJ, Francis GA, Romney JS, Gilchrist DM, Opgenorth A, Gyenes GT.

Can J Cardiol. 2006 Sep;22(11):939-45.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk